Advertisement
Loading...

Innate Pharma S.A.

IPHYF•PNK
Healthcare
Biotechnology
$2.25
$0.00(0.00%)
U.S. Market is Open • 15:37

Innate Pharma S.A. (IPHYF) Stock Overview

Explore Innate Pharma S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap211.3M
P/E Ratio-3.60
EPS (TTM)$-0.64
ROE5.94%
Fundamental Analysis

AI Price Forecasts

1 Month$1.79
3 Months$1.14
1 Year Target$1.85

IPHYF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Innate Pharma S.A. (IPHYF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 70.56, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $1.85.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.60 and a market capitalization of 211.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
3.21%
1-Month Change
50.00%
3-Month Change
4.65%
6-Month Change
12.50%
Year-to-Date (YTD) Change
4.65%
1-Year Change
55.17%
3-Year Change
-23.21%
5-Year Change
-40.79%
All-Time (Max) Change
-85.51%

Contact Information

https://www.innate-pharma.com
33 4 30 30 30 30
117, Avenue de Luminy, Marseille, NaN, 13009

Company Facts

181 Employees
IPO DateJun 9, 2015
CountryFR
Actively Trading

Frequently Asked Questions